Article

RA trend reversal: Incidence on the rise in women

After a sharp decline in the incidence of rheumatoid arthritis (RA) over the previous 4 decades, it appears to have increased slightly in women in more recent years, along with an increase in prevalence.

After a sharp decline in the incidence of rheumatoid arthritis (RA) over the previous 4 decades, it appears to have increased slightly in women in more recent years, along with an increase in prevalence. The reasons are unknown, but the cumulative effect of multiple environmental factors (eg, cigarette smoking, vitamin D deficiency, infections, immunizations, obesity, and socioeconomic status) may play a role.

Myasoedova and colleagues assembled a population-based incidence cohort of persons 18 years or older who fulfilled the American College of Rheumatology 1987 criteria for the classification of RA. Overall incidence rates were age- and sex-adjusted to the population of white persons in the United States in 2000.

For the 1995-2007 period, the overall age- and sex-adjusted annual RA incidence was 40.9 per 100,000 population. The age-adjusted incidence in women was 53.1 per 100,000 population, compared with 27.7 per 100,000 in men. During that period, the incidence of RA increased moderately in women but not in men. The overall age- and sex-adjusted prevalence on January 1, 2005, was 0.72%, compared with a prevalence of 0.62% in 1995.

The authors noted that the effect of other, as yet unknown risk factors on changes in RA incidence over time cannot be excluded.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2025 MJH Life Sciences

All rights reserved.